Skip to main content
SpringerLink
Log in

Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma

  • Letter to the Editor
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Broggi G, Barresi V (2023) Assessment of CDKN2A/B homozygous deletion in gliomas: to FISH or not to FISH? J Neuropathol Exp Neurol 82:742–744. https://doi.org/10.1093/jnen/nlad045

    Article  PubMed  Google Scholar 

  2. Ikeda H, Yamaguchi S, Ishi Y, Wakabayashi K, Shimizu A, Kanno-Okada H, Endo T, Ota M, Okamoto M, Motegi H, Iwasaki N, Fujimura M (2023) Supratentorial multifocal gliomas associated with Ollier disease harboring IDH1 R132H mutation: a case report. Neuropathology 43:413–420. https://doi.org/10.1111/neup.12902

    Article  PubMed  Google Scholar 

  3. Komori T (2022) The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles. Brain Tumor Pathol 39:47–50. https://doi.org/10.1007/s10014-022-00428-3

    Article  PubMed  Google Scholar 

  4. Masui K, Onizuka H, Nitta M, Muragaki Y, Kawamata T, Komori T (2023) Recurrent high-grade astrocytoma with somatic mosaicism of isocitrate dehydrogenase gene mutation. Pathol Int 73:144–146. https://doi.org/10.1111/pin.13308

    Article  CAS  PubMed  Google Scholar 

  5. Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF (2023) Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med. https://doi.org/10.1056/NEJMoa2304194

    Article  PubMed  Google Scholar 

  6. Nicholson JG, Fine HA (2021) Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov 11:575–590. https://doi.org/10.1158/2159-8290.CD-20-1474

    Article  CAS  PubMed  Google Scholar 

  7. Satomi K, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Narita Y, Ichimura K, Yoshida A (2021) Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma. Mod Pathol 34:688–700. https://doi.org/10.1038/s41379-020-00701-w

    Article  CAS  PubMed  Google Scholar 

  8. Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi JI, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D, Unterberg A, Pfister SM, Jones DTW, van den Bent M, Hegi M, French P, Baumert BG, Stupp R, Gorlia T, Weller M, Capper D, Korshunov A, Herold-Mende C, Wick W, Louis DN, von Deimling A (2018) Novel, improved grading system (s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153–166. https://doi.org/10.1007/s00401-018-1849-4

    Article  CAS  PubMed  Google Scholar 

  9. Umehara T, Arita H, Yoshioka E, Shofuda T, Kanematsu D, Kinoshita M, Kodama Y, Mano M, Kagawa N, Fujimoto Y, Okita Y, Nonaka M, Nakajo K, Uda T, Tsuyuguchi N, Fukai J, Fujita K, Sakamoto D, Mori K, Kishima H, Kanemura Y (2019) Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts. Acta Neuropathol Commun 7:99. https://doi.org/10.1186/s40478-019-0749-8

    Article  CAS  PubMed  Google Scholar 

  10. Xi S, Huang Q, Zeng J (2024) A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma. J Neuropathol Exp Neurol 83:125–130. https://doi.org/10.1093/jnen/nlad112

    Article  PubMed  Google Scholar 

  11. Yoshimoto M, Ludkovski O, Good J, Pereira C, Gooding RJ, McGowan-Jordan J, Boag A, Evans A, Tsao MS, Nuin P, Squire JA (2018) Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Lab Invest 98:403–413. https://doi.org/10.1038/s41374-017-0007-2

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank medical technologists at Tokyo Women’s Medical University for their helpful assistance. KM, HO and TK conducted the neuropathological examinations; YM and TK performed the surgery and compiled the clinical records; KM, AK and TK drafted the manuscript; all the authors reviewed the manuscript.

Funding

This work was supported in part by Grant-in-Aid from Takeda Science Foundation and Japan Society for the Promotion of Science KAKENHI Grant JP23K06487 (KM).

Author information

Authors and Affiliations

  1. Department of Pathology, Tokyo Women’s Medical University, Tokyo, Japan

    Kenta Masui & Atsushi Kurata

  2. Department of Pathology, Kyorin University, Tokyo, Japan

    Hiromi Onizuka

  3. Center for Advanced Medical Engineering Research and Development, Kobe University, Hyogo, Japan

    Yoshihiro Muragaki

  4. Department of Neurosurgery, Tokyo Women’s Medical University Hospital, Tokyo, Japan

    Yoshihiro Muragaki & Takakazu Kawamata

  5. Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan

    Takashi Komori

Authors
  1. Kenta Masui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiromi Onizuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshihiro Muragaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takakazu Kawamata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atsushi Kurata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takashi Komori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenta Masui.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Approval of the research protocol

The ethical committees of Tokyo Women’s Medical University (3540-R6).

Animal studies

Not applicable.

Research involving recombinant DNA

Not applicable.

Informed consent

Written informed consent was obtained.

Registry and the registration no. of the study/trial

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masui, K., Onizuka, H., Muragaki, Y. et al. Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma. Brain Tumor Pathol 41, 92–95 (2024). https://doi.org/10.1007/s10014-024-00484-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-024-00484-x

Keywords

Search

Navigation